# Safety, Efficacy and Acceptability of Flavocoxid (Limbrel)A Pilot Study

> **NCT00303017** · NA · COMPLETED · sponsor: **Primus Pharmaceuticals** · enrollment: 60 (actual)

## Conditions studied

- Osteoarthritis

## Interventions

- **DIETARY_SUPPLEMENT:** flavocoxid
- **DRUG:** Naproxen

## Key facts

- **NCT ID:** NCT00303017
- **Lead sponsor:** Primus Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-03
- **Primary completion:** 2006-07
- **Final completion:** 2006-09
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2015-10-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00303017

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00303017, "Safety, Efficacy and Acceptability of Flavocoxid (Limbrel)A Pilot Study". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT00303017. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*